Author

Alex Chang

Associate Professor, Geisinger - Cited by 57,446 - kidney disease - hypertension - obesity - genetics - clinical trials

Biography

Dr. Chang, who is a Clinical Investigator in Nephrology at Geisinger Health System, will conduct his research at Johns Hopkins University in the Prohealth Research Unit directed by Dr. Lawrence Appel. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. He has published many papers in the International Journals. He is the Editorial Board Member of Translational Medicine and serves as a member of various associations. His research interests includes chronic kidney disease, Dialysis, Nephrology.
Title
Cited by
Year
Modifiable lifestyle behaviors and CKD progression: a narrative review
SJ Schrauben, BJ Apple, AR ChangKidney360 3 (4), 752, 2022202
13
2022
Obesity and chronic kidney disease in US adults with type 1 and type 2 diabetes mellitus
AS Wallace, AR Chang, JI Shin, J Reider, JB Echouffo-Tcheugui, ...The Journal of Clinical Endocrinology & Metabolism 107 (5), 47-56, 2022202
12
2022
BMI and blood pressure control among United States adults with hypertension
K Foti, ST Hardy, AR Chang, E Selvin, J Coresh, P MuntnerJournal of hypertension 40 (4), 741-74, 2022202
8
2022
Association of rosuvastatin use with risk of hematuria and proteinuria
JI Shin, DM Fine, Y Sang, A Surapaneni, SC Dunning, LA Inker, TD Nolin, ...Journal of the American Society of Nephrology 33 (9), 16-1, 2022202
7
2022
Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: a population-based study
B Lyu, AR Chang, LA Inker, E Selvin, ME Grams, JI ShinThe Lancet Regional Health–Americas 11, 2022202
6
2022
Progression of chronic kidney disease risk categories and risk of cardiovascular disease and total mortality: coronary artery risk development in young adults cohort
Y Choi, DR Jacobs Jr, GR Shroff, H Kramer, AR Chang, DA DuprezJournal of the American Heart Association 11 (21), e02668, 2022202
5
2022
Exome sequencing of a clinical population for autosomal dominant polycystic kidney disease
AR Chang, BS Moore, JZ Luo, G Sartori, B Fang, S Jacobs, Y Abdalla, ...JAMA 328 (24), 2412-2421, 2022202
5
2022
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP
K Matsushita, S Kaptoge, SHJ Hageman, Y Sang, SH Ballew, ME Grams, ...European journal of preventive cardiology 30 (1), 8-16, 2023202
5
2023
The KIDNEYCODE Program: Diagnostic Yield and Clinical Features of Individuals with CKD
KV Lieberman, AR Chang, GA Block, K Robinson, SL Bristow, A Morales, ...Kidney360 3 (5), 900, 2022202
4
2022
Establishing a national cardiovascular disease surveillance system in the United States using electronic health record data: Key strengths and limitations
BA Williams, S Voyce, S Sidney, VL Roger, TB Plante, S Larson, ...Journal of the American Heart Association 11 (8), e0209, 2022202
4
2022
Cardiovascular effects of home dialysis therapies: a scientific statement from the American Heart Association
MJ Sarnak, BL Auguste, E Brown, AR Chang, GM Chertow, M Hannan, ...Circulation 146 (11), e146-e164, 2022202
3
2022
Pharmacologic treatment of type 2 diabetes in the US, Sweden, and Israel
Pharmacologic treatment of type diabetes in the US, Sweden, and IsraelB Lyu, Y Sang, E Selvin, AR Chang, GC Alexander, CM Cohen, J Coresh, ...Diabetes care 45 (1), 96-934, 0
2
2022
Telehealth versus Self-Directed Lifestyle Intervention to Promote Healthy Blood Pressure: a Randomized Controlled Trial
AR Chang, L Gummo, C Yule, H Bonaparte, C Collins, A Naylor, L Appel, ...medRxiv, 0.03. 31.7348, 0
2
2022
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study
PB Mark, JJ Carrero, K Matsushita, Y Sang, SH Ballew, ME Grams, ...European heart journal 44 (13), 1157-1166, 030
2
2023
Effect of age and rural residency on perceptions about SARS‐CoV‐2 pandemic and vaccination in kidney transplant recipients
G Singh, J DeWalle, B Tanriover, N Singh, AR Chang, PM AnandTransplant Infectious Disease 24 (6), e3943, 2022202
1
2022
Baclofen and the risk of encephalopathy: a real-world, active-comparator cohort study
YJ Hwang, AR Chang, DJ Brotman, LA Inker, ME Grams, JI ShinMayo Clinic Proceedings 98 (5), 676-688, 2023202
1
2023
Processes of Care in Survivors of Acute Kidney Injury followed in Specialized Postdischarge Clinics
V Ortiz-Soriano, G Singh, A Chang, EF Ruiz, R Wald, SA Silver, JA NeyraClinical Journal of the American Society of Nephrology 7 (), 669-672, 2022202
1
2022
Effects of the Dietary Approaches to Stop Hypertension Diet on Change in Cardiac Biomarkers Over Time: Results From the DASH‐Sodium Trial
MJ Belanger, LC Kovell, RA Turkson‐Ocran, KJ Mukamal, X Liu, LJ Appel, ...Journal of the American Heart Association 2 (2), e026684, 2023202
1
2023
A national registry for people with all stages of kidney disease: the National Kidney Foundation (NKF) Patient Network
LA Inker, S Ferrè, M Baliker, A Barr, L Bonebrake, AR Chang, J Chaudhari, ...American Journal of Kidney Diseases 8 (2), 20-22. e, 2023202
1
2023
Are Digital Health Technologies and Models of Nutrition Care the Future of Chronic Kidney Disease Management?
JT Kelly, DK Jegatheesan, J Dawson, A Barnett, BH Khor, AR Chang, ...Journal of Renal Nutrition, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=bWCllO8AAAAJ&hl=en

Cited by
Citations 57446
h-index 46
i10-index 93
Recommended Journals
Open Access Journals